Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Invested Capital (2016 - 2025)

Historic Invested Capital for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $10.0 million.

  • Nephros' Invested Capital rose 2241.25% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 2241.25%. This contributed to the annual value of $8.6 million for FY2024, which is 271.6% up from last year.
  • Latest data reveals that Nephros reported Invested Capital of $10.0 million as of Q3 2025, which was up 2241.25% from $9.6 million recorded in Q2 2025.
  • In the past 5 years, Nephros' Invested Capital registered a high of $15.8 million during Q1 2021, and its lowest value of $7.9 million during Q2 2024.
  • In the last 5 years, Nephros' Invested Capital had a median value of $9.3 million in 2025 and averaged $10.7 million.
  • In the last 5 years, Nephros' Invested Capital surged by 3351.34% in 2021 and then tumbled by 4030.81% in 2022.
  • Nephros' Invested Capital (Quarter) stood at $15.0 million in 2021, then plummeted by 40.31% to $9.0 million in 2022, then decreased by 6.64% to $8.4 million in 2023, then rose by 2.72% to $8.6 million in 2024, then increased by 16.55% to $10.0 million in 2025.
  • Its last three reported values are $10.0 million in Q3 2025, $9.6 million for Q2 2025, and $9.3 million during Q1 2025.